← All trials
NCT00015340
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 1999
- Primary completion
- Aug 1, 2001
- Completion date
- Sep 1, 2001
- First posted
- —
- Last posted
- —
- Enrollment
- 582
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute on Drug Abuse (NIDA)Lead sponsor
- Department of Veteran AffairsStudy chair
- New York MDRUCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.